In the News

413 News Items found
colorful microscope image of cancer cells
MSK scientists are shedding new light on a tumor’s earliest moments — revealing how lung cells with cancer-causing mutations recruit accomplices from healthy surrounding tissue to pave the way for a tumor to develop.
physiatrist Jesuel Padro-Guzman
Q&A
Peripheral neuropathy is a common side effect of many types of chemotherapy. Learn about what it is, why it happens, and how to treat CIPN.
AACR 2019 Annual Meeting
In the News
Read up on the latest developments in several important areas of cancer research emerging from the 2019 American Association for Cancer Research annual meeting.
Jianjiong Gao, Hongxin Zhang, Nikolaus Schultz, Debyani Chakravarty, and Sarah Suehnholz stand together on a terrace
Feature
OncoKB, a database developed and maintained by investigators at MSK, helps match patients with targeted therapies based on the mutations found in their tumors.
Two nurses talking at a desk
Feature
Deep bonds are forged between MSK’s specialized nurses and their patients during first-in-human trials.
Ingo Mellinghoff
A multicenter team led by Memorial Sloan Kettering neurologist and researcher Ingo K. Mellinghoff has uncovered the relationship between two proteins that play a critical role in glioblastoma, the most common form of brain cancer.
MSK scientists Margaret Callahan, Ronglai Shen, and Katherine Panageas
A blood-based test identifies patients in whom immunotherapy may ‘LAG.’
Sign for AACR scientific meeting featuring collage of images
Roundup
Read up on the latest developments in several key areas of cancer research, including genomic mapping, disease modeling through CRISPR, CAR T therapy, and cancer stem cells.
Charles Sawyers presents at AACR 2026
Dozens of clinicians and scientists from across MSK presented the latest advances in cancer research at the 2026 American Association for Cancer Research (AACR) Annual Meeting, held April 17 to 22 in San Diego.
Dr. Christopher Klebanoff
Feature
Learn how MSK physician-scientist Christopher Klebanoff is working to bring immunotherapy to more patients, especially those with solid tumors.